New Key Statistics Module, Z-Score and F-Score
NAS:CCCC Key Ratios
Market Cap $ M | 440.30 |
Enterprise Value $ M | 248.77 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 1.77 |
Price/Sales | 12.52 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 29.00 |
EPS (TTM) $ | -1.90 |
Beneish M-Score | -2.16 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 8.70 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -2.34 |
EV-to-EBITDA | -2.38 |
PEG | -- |
Shares Outstanding M | 69.34 |
Net Margin (%) | -367.17 |
Operating Margin % | -396.42 |
Pre-tax Margin (%) | -362.82 |
Quick Ratio | 5.09 |
Current Ratio | 5.09 |
ROA % (ttm) | -28.94 |
ROE % (ttm) | -44.90 |
ROIC % (ttm) | -81.96 |
Dividend Yield % | -- |
Altman Z-Score | -0.29 |
CCCC Number of Guru Trades
CCCC Volume of Guru Trades
Gurus Latest Trades with NAS:CCCC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CCCC is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
C4 Therapeutics Inc Insider Transactions
No Available Data
News about NAS:CCCC
Total 0- 1